SOURCE: Sinclair Pharma PLC

November 16, 2006 09:25 ET

SINCLAIR PHARMA PLC - PIPER JAFFRAY CONFERENCE

Surrey, UK -- (MARKET WIRE) -- November 16, 2006 --

                   Sinclair Pharma plc presenting at

         Piper Jaffray  Annual Global Healthcare Conference

16 November 2006, Godalming, UK - Sinclair Pharma plc (AIM: SPH.L), the international specialty pharmaceutical company today announces that its Chief Executive Officer, Dr Michael Flynn, and Chief Financial Officer Jerry Randall, will be presenting at the Piper Jaffray Health Care Conference at the Pierre Hotel, New York, on Wednesday 29th November at 3.30pm.

A live webcast of Sinclair's presentation will be available at http://www.piperjaffray.com/hcwebcast. The presentation and further company information will also be available at www.sinclairpharma.com.

Sinclair Pharma plc

Sinclair Pharma plc is an international specialty pharmaceutical company. It has a growing sales and marketing operation that is already present in France, Italy, the UK, Spain and Portugal, and a complementary marketing partner network that spans 60 countries.

Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market within a short time frame. The company focuses on niche therapeutic areas and its current portfolio includes products for dermatological conditions and oral health.

Enquiries:

Sinclair Pharma plc                   Tel:      +44 1483 410 600
Zoe McDougall                                   +44 7973 792 520

John Barrington-Carver                Tel:      +44 7831 655 630
Sinclair US

Mike Killeen                          Tel       +1 972 478 4380


                      This information is provided by RNS
            The company news service from the London Stock Exchange